On August 19, 2026, the National Medical Products Administration (NMPA) of China listed four new cosmetic ingredients in Catalog II of the Ingredient List Management of Cosmetic Ingredients (IECIC) after completing a three-year safety monitoring period and evaluation. IECIC refers to the list of cosmetic ingredients for ingredient management, which is divided into Catalog I and Catalog II.- Cata..

On June 12, 2026, Hong Kong's Medical Device Division (MDD) updated Guidance Note "GN-02" for Class II, III, and IV General Medical Devices, as well as Guidance Note "GN-06" for Class B, C, and D In Vitro Diagnostic Medical Devices (IVDMDs). Effective immediately, the revised guidance added new Section "E001", allowing applicants to request priority consideration for qualifying "innovative medic..

On August 7, 2026, the Ministry of Food and Drug Safety (MFDS) of Korea has announced a draft guideline on Braille labeling for cosmetics to provide easy-to-understand guidance on necessary information when displaying cosmetic labeling details on containers or packaging using Braille or codes for voice/sign language conversion, in order to ensure the safe use of cosmetics by visually or hearing ..

On August 10, 2026, The Ministry of Food and Drug Safety (MFDS) of Korea has announced a partial amendment to the “Regulations on Approval, Notification, and Review of In Vitro Diagnostic Medical Devices” to rationally operate the approval and review system for in vitro diagnostic medical devices by minimizing usage errors by general consumers, through the establishment of grounds for submitting..

On July 30, 2026, Indonesia’s Halal Product Assurance Organizing Body (BPJPH) notified the WTO via G/TBT/N/IDN/190, soliciting comments on the "Draft Regulation on the Conformity Assessment of Foreign Halal Products Entering the Territory of Indonesia". The draft introduces a key additional step for halal products exported to Indonesia, including cosmetics: any imported product that must obtain ..

On July 21, 2026, the Central Drugs Standard Control Organization (CDSCO) released its final Guidance Document on Medical Device Software (Document No. CDSCO/MD/GD/MDSW/01/2026) under the Medical Device Rules, 2017 (MDR 2017). The guidance applies to any software qualifying as a medical device under MDR 2017, including standalone software, embedded software, mobile apps, AI/ML-based tools, and c..

On July 29, 2026, the National Medical Products Administration (NMPA) officially issued the Announcement on Matters Concerning Cosmetic Registration and Notification. Effective upon issuance, the Announcement aims to further optimize China’s cosmetic registration and notification procedures in line with the Opinions on Deepening the Reform of Cosmetic Administration and Promoting the High-Qualit..

On July 28, 2026, The Ministry of Food and Drug Safety (MFDS) of the Republic of Korea has revised its Guidelines for Medical Device Software Validation to reflect the latest international standards. This guideline aims to ensure the safety and performance of medical device software being developed by providing the scope, methodologies, and reference templates required for software validation du..

On July 3, 2026, in the newly released “2026 Regulatory Plan and Unified Agenda,” the US Food and Drug Administration (FDA) placed two important cosmetics-related rules in the “Proposed Rule Stage,” with the aim of issuing Notices of Proposed Rulemaking (NPRM) in 2026: first, to prohibit the use of formaldehyde and formaldehyde-releasing chemicals in hair smoothing/straightening products; and se..

On July 8, 2026, a new Thai FDA notification took effect that sets out exactly what happens to unsold medical device stock when an establishment registration, license, or notification receipt expires or isn’t renewed. License holders now face a strict three-step timeline for reporting and selling that remaining inventory. The notification lays out exactly what happens to remaining medical device..